The HHS and FDA have released further details of their plans to remove all petroleum-based synthetic dyes from the nation's food supply.

The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) on April 22, 2025, announced their intent to ...

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...

In addition, HHS Secretary Robert F. Kennedy Jr. addressed the delay in Novavax's approval in a CBS interview earlier this ...

The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) just announced a prominent ...

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...

Tharimmune, Inc., (Nasdaq:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently ...

A study published last week suggests that, if vaccine uptake continues to decline, measles will soon be endemic again in the ...

HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...